L'intérêt à découvert pour Intellia Therapeutics donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Intellia Therapeutics. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Intellia Therapeutics (NASDAQ:NTLA) Stock, Rapport sur les intérêts à découvert

INTELLIA THERAPEUTICS INC

Intellia Therapeutics

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

Stifel analyst Jim Duffy maintains Under Armour (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) with a Buy and lowers the price target from $11 to $10.

News

Price Target

Analyst Ratings

Stifel Maintains Buy on Under Armour, Lowers Price Target to $10

Smartphone makers like Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) are hoping that consumers will trade in their phones for <a href="https://www.benzinga.com/tech/25/04/44850406/apples-foldable-iphone-rumors-gain-steam-as-stock-slides-could-a-2000-device-spark-a-comeback">new ones in the next year</a>, an item that could lock in additional revenue and higher margins.
A new Benzinga poll finds that the percentage of people who have upgraded their phones in the last 12 months is below 50%.
What Happened: Analysts highlight that users upgrading their Apple iPhones could help the technology giant boost <a href="https://www.benzinga.com/news/earnings/25/05/45152493/apple-reports-strong-q2-earnings-revenue-beat-eps-beat-installed-base-hits-all-time-high-across-all-segments-100-billion-buyback-and-more">its annual revenue</a> after releasing the iPhone 16 in September 2024 and getting ready to release the iPhone 17 in the future.
Benzinga polled readers to find out where they stand in the upgrade cycle.
"Which of the following describes your smartphone currently?" Benzinga asked.
Here were the results:
<ul class="wp-block-list">
<li>I own an iPhone and have not gotten a new phone in the last 12 months: 38%</li>
<li>I own an iPhone and got a new phone in the last 12 months: 22%</li>
<li>I own a different smartphone and have gotten a new phone in the last 12 months: 17%</li>
<li>I own a different smartphone and have not gotten a new phone in the last 12 months: 15%</li>
<li>I don't own a smartphone: 8%</li>
</ul>
The poll found that 53.5% of consumers have not upgraded their smartphones in more than 12 months, or an even higher percentage if stripping out the 8% who answered that they don't own a smartphone. The poll found that 38.6% of respondents have upgraded their smartphones in the last 12 months.
Another important finding in the poll was the strong brand power that Apple commands, with 60.4% of the users answering the question saying they own an iPhone.
Read Also: <a href="https://www.benzinga.com/tech/25/05/45357613/china-tariff-de-escalation-biggest-winners-include-tesla-apple-new-tech-highs-back-on-the-table-now-for-2025">China Tariff De-Escalation Biggest Winners Include Tesla, Apple: &#8216;New Tech Highs Back On The Table Now For 2025&#8217;</a>
Why It's Important: The fact that over 50% of users said they have not upgraded their smartphone in more than 12 months could bode well for Apple in the next iPhone release cycle.
Also potentially helping Apple would be the growth of AI features like Apple Intelligence with the iPhone 17. Apple Intelligence released in October 2024, a month after the iPhone 16 released.
While users could upgrade to experience Apple Intelligence, the full benefits of an upgrade cycle may not have been realized by Apple and could be hit with a new iPhone that comes standard with Apple Intelligence features.
Benzinga also asked users which feature is the most important when considering a phone upgrade.
"Which of the following is the most important reason to upgrade to a new phone?" Benzinga asked.
The results were:
<ul class="wp-block-list">
<li>Old phone feels outdated: 28%</li>
<li>Artificial intelligence features: 27%</li>
<li>Better battery life: 26%</li>
<li>Batter camera: 19%</li>
</ul>
The poll found that an outdated phone, which could mean a number of things, is the most important factor when considering an upgrade. Ranking second could be the key for Apple's future success with artificial intelligence features the second-most important reason to upgrade a smartphone.
The study was conducted by Benzinga from May 5, 2025, through May 9, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 316 adults.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/04/45112477/exclusive-if-meta-is-forced-to-divest-instagram-whatsapp-or-facebook-43-pick-this-standout">EXCLUSIVE: If Meta Is Forced To Divest Instagram, WhatsApp, Or Facebook, 43% Pick This Standout</a></li>
</ul>

Exclusives

Tech

Trading Ideas

AAPL

EXCLUSIVE: Apple Stock Could Benefit From Smartphone Upgrade Cycle, Poll Ranks Top Reason For Trade In (It's Not The Camera)

<a href="https://www.benzinga.com/news/25/04/44590350/courtroom-clash-no-thank-you-sparks-lawsuit-as-altman-shuts-down-musks-97-4b-bid">Elon Musk </a>is setting the stage for what could be one of the artificial intelligence industry&#8217;s biggest financial leaps. During a recent investor update on April 21, first shared with <a href="https://www.youtube.com/watch?v=XH5O_X1xG2o">CNBC</a>, Musk said he wants to assign a &#8220;proper value&#8221; to his AI startup, xAI.&nbsp;
He didn't confirm a new fundraising round, but his comment hinted at possible funding from Middle Eastern sovereign wealth funds and global investors, according to people familiar with the matter. This comes after xAI secured $6 billion in late 2024, giving the company a $50 billion valuation, <a href="https://www.forbes.com/sites/antoniopequenoiv/2024/12/23/xai-valuation-reaches-over-40-billion-after-6-billion-funding-round/">Forbes reported</a>.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
<h2 class="wp-block-heading">A Big Bet On AI Infrastructure</h2>
The $6 billion raise wasn&#8217;t for buzz—it powered the expansion of &#8220;Colossus,&#8221; xAI&#8217;s supercomputer in Memphis.&nbsp;
Colossus is built with 100,000 Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) H100 GPUs and was designed to train xAI&#8217;s large language model, Grok, and is seemingly one of the most powerful AI clusters to date.
Musk&#8217;s ambitions don&#8217;t end there. As reported by the <a href="https://www.ft.com/content/53eeadd8-8fec-4f1b-991e-642e24959e02">Financial Times</a>, Musk already has plans to deploy more than 1 million GPUs, which will require scaling up Colossus. The additional capacity would give xAI a significant edge in the generative AI race, putting it in competition with established players like OpenAI and Anthropic.
Trending: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
Meanwhile, in March, xAI finalized a $33 billion all-stock merger with Musk&#8217;s other venture, X. The combination integrates xAI&#8217;s technology with X&#8217;s social media ecosystem. Musk said in an <a href="https://x.com/elonmusk/status/1905731750275510312?lang=en">X post</a> that the move will provide smarter, and more meaningful experiences to billions of people.
It also solidifies xAI's revenue stream, which industry intelligence platform <a href="https://sacra.com/c/xai/">Sacra</a> estimates at about $100 million annually, primarily from X Premium subscriptions and API services.
After the merger, Musk<a href="https://x.com/elonmusk/status/1905731750275510312"> posted on X</a>, &#8220;This combination will unlock immense potential by blending xAI&#8217;s advanced AI capability and expertise with X&#8217;s massive reach.&#8221; ​His goal? To streamline AI into everyday digital interactions.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
Another layer of potential investment surfaced in July. After running a public<a href="https://x.com/elonmusk/status/1815907844434112999?s=46=PySpYjNmRDrcisnq5IFhJQ"> poll on X</a>, Musk proposed bringing a $5 billion investment from Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) into xAI to the automaker&#8217;s board.&nbsp;
The poll revealed that 67.9% of voters supported the idea of Tesla investing $5 billion in his artificial intelligence startup, xAI. The initiative could link xAI&#8217;s capabilities directly to Tesla&#8217;s self-driving software and in-vehicle AI systems.
Looking forward, Bloomberg reported that <a href="https://www.benzinga.com/news/25/04/44725803/musks-xai-aims-for-1-million-gpus-in-memphis-but-can-the-citys-grid-handle-a-27b-ai-power-surge">xAI</a> is <a href="https://www.bloomberg.com/news/articles/2025-02-14/musk-s-xai-discussing-10-billion-raise-at-75-billion-valuation">seeking </a>to raise an additional $10 billion, potentially pushing its valuation to $75 billion. the funding goal in February and would place xAI in the same financial orbit as top AI labs.
Read Next:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
Image: Shutterstock

NVDA

TSLA

Elon Musk Wants A 'Proper Value' For xAI — After $6 Billion Raise, 100,000 GPUs, And A Quiet $100 Million Deal Most Missed

WIIM

CINT

CINT stock has given up its prior loss. CI&T shares were trading lower after the company reported worse-than-expected Q1 financial results.

Stifel analyst Jim Duffy maintains On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Buy and raises the price target from $57 to $66.

ONON

Stifel Maintains Buy on On Holding, Raises Price Target to $66

Canaccord Genuity analyst Austin Moeller maintains Intuitive Machines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) with a Buy and raises the price target from $21 to $21.5.

LUNR

Canaccord Genuity Maintains Buy on Intuitive Machines, Raises Price Target to $21.5

GSIW

Garden Stage Shares Halted On Circuit Breaker To The Upside, Stock Now Up 69%

Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) has outperformed the market over the past 5 years by 10.51% on an annualized basis producing an average annual return of 25.53%. Currently, Cencora has a market capitalization of $54.16 billion. 
Buying $100 In COR: If an investor had bought $100 of COR stock 5 years ago, it would be worth $313.24 today based on a price of $279.60 for COR at the time of writing.
<h3>Cencora's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747237519_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) with a Hold and lowers the price target from $6 to $5.

MGNX

Stifel Maintains Hold on Macrogenics, Lowers Price Target to $5

Canaccord Genuity analyst Kyle Mikson maintains GRAIL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>) with a Buy and raises the price target from $32 to $43.

GRAL

Canaccord Genuity Maintains Buy on GRAIL, Raises Price Target to $43

RBC Capital analyst Keith Mackey maintains Trican Well Service (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TCW#TSX">TCW</a>) with a Outperform and raises the price target from C$5.5 to C$6.

TSX:TCW

RBC Capital Maintains Outperform on Trican Well Service, Raises Price Target to C$6

Stifel analyst J. Bruce Chan maintains Landstar System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTR#NASDAQ">LSTR</a>) with a Hold and lowers the price target from $147 to $140.

LSTR

Stifel Maintains Hold on Landstar System, Lowers Price Target to $140

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENOV#NYSE">ENOV</a>) with a Buy and lowers the price target from $75 to $70.

ENOV

Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $70

Canaccord Genuity analyst Kyle Mikson maintains Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) with a Buy and lowers the price target from $2.5 to $1.5.

BDSX

Canaccord Genuity Maintains Buy on Biodesix, Lowers Price Target to $1.5

Health In Tech Shares Resume Trade

<a href="https://www.whitehouse.gov/fact-sheets/2025/05/fact-sheet-president-donald-j-trump-secures-historic-1-2-trillion-economic-commitment-in-qatar/" title="https://www.whitehouse.gov/fact-sheets/2025/05/fact-sheet-president-donald-j-trump-secures-historic-1-2-trillion-economic-commitment-in-qatar/">https://www.whitehouse.gov/fact-sheets/2025/05/fact-sheet-president-donald-j-trump-secures-historic-1-2-trillion-economic-commitment-in-qatar/</a>

Contracts

Global

Trump Secures Historic $1.2T Economic Commitment In Qatar; Deals With Qatar Include More Than $243B, Including Sale Of Boeing Aircraft And GE Aerospace Engines To Qatar Airways; Qatar Airways To Acquire 210 Boeing 787 Dreamliner And 777x Aircraft Powered By GE Aerospace Engines; Raytheon Secures $1B Agreement For Qatar Acquisition Of Counter-Drone Capabilities; General Atomics Secured A Nearly $2B Agreement For Qatar's Acquisition Of The MQ-9B Remotely Piloted Aircraft System

Susquehanna analyst Christopher Rolland maintains Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Neutral and raises the price target from $100 to $110.

SLAB

Susquehanna Maintains Neutral on Silicon Laboratories, Raises Price Target to $110

RBC Capital analyst Ken Herbert maintains Karman Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRMN#NYSE">KRMN</a>) with a Outperform and raises the price target from $38 to $44.

KRMN

RBC Capital Maintains Outperform on Karman Holdings, Raises Price Target to $44

Susquehanna analyst James Friedman maintains PagSeguro Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAGS#NYSE">PAGS</a>) with a Positive and lowers the price target from $16 to $14.

PAGS

Susquehanna Maintains Positive on PagSeguro Digital, Lowers Price Target to $14

Rumors

IPOs

ETOR

Etoro Group IPO Price Indicating $70 On 770K Shares; IPO Priced At $52/Share On 11,923,018 Shares

Small Cap

Press Releases

NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA

Comments

Intellia Therapeutics

Intérêt court

Intellia Therapeutics (NASDAQ:NTLA) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL